CO5580773A2 - Rosuvastatina en estados pre dementes - Google Patents

Rosuvastatina en estados pre dementes

Info

Publication number
CO5580773A2
CO5580773A2 CO04035705A CO04035705A CO5580773A2 CO 5580773 A2 CO5580773 A2 CO 5580773A2 CO 04035705 A CO04035705 A CO 04035705A CO 04035705 A CO04035705 A CO 04035705A CO 5580773 A2 CO5580773 A2 CO 5580773A2
Authority
CO
Colombia
Prior art keywords
rosuvastatina
dement
states
patient
dementia
Prior art date
Application number
CO04035705A
Other languages
English (en)
Inventor
Hans Basun
Timothy PISER
Ihor Rak
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5580773A2 publication Critical patent/CO5580773A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)

Abstract

1.- Un método para prevenir la demencia en un paciente que comprende administrar a un paciente en riesgo de desarrollar demencia una cantidad efectiva de rosuvastatina o su sal farmacéuticamente aceptable.
CO04035705A 2001-10-19 2004-04-19 Rosuvastatina en estados pre dementes CO5580773A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states

Publications (1)

Publication Number Publication Date
CO5580773A2 true CO5580773A2 (es) 2005-11-30

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04035705A CO5580773A2 (es) 2001-10-19 2004-04-19 Rosuvastatina en estados pre dementes

Country Status (19)

Country Link
US (1) US20060229321A1 (es)
EP (1) EP1446123A1 (es)
JP (1) JP2005505605A (es)
KR (1) KR20040058201A (es)
CN (1) CN1604780A (es)
AR (1) AR036891A1 (es)
BR (1) BR0213434A (es)
CA (1) CA2463597A1 (es)
CO (1) CO5580773A2 (es)
HU (1) HUP0401798A3 (es)
IL (1) IL161380A0 (es)
IS (1) IS7218A (es)
MX (1) MXPA04003631A (es)
NO (1) NO20041840L (es)
PL (1) PL369573A1 (es)
RU (1) RU2004112422A (es)
SE (1) SE0103509D0 (es)
WO (1) WO2003032995A1 (es)
ZA (1) ZA200402844B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023778A2 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
TW200526596A (en) 2003-11-24 2005-08-16 Teva Pharma Crystalline ammonium salts of rosuvastatin
US7244844B2 (en) 2003-12-02 2007-07-17 Teva Pharmaceutical Industries Ltd. Reference standard for characterization of rosuvastatin
CA2573857A1 (en) 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
KR100945763B1 (ko) 2005-02-22 2010-03-08 테바 파마슈티컬 인더스트리즈 리미티드 로수바스타틴의 제조 방법
TW200800917A (en) 2005-08-16 2008-01-01 Teva Pharma Crystalline rosuvastatin intermediate
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
PL369573A1 (en) 2005-05-02
ZA200402844B (en) 2005-01-24
BR0213434A (pt) 2004-11-09
MXPA04003631A (es) 2004-07-30
KR20040058201A (ko) 2004-07-03
IS7218A (is) 2004-04-13
JP2005505605A (ja) 2005-02-24
HUP0401798A2 (hu) 2005-01-28
HUP0401798A3 (en) 2005-06-28
CA2463597A1 (en) 2003-04-24
NO20041840L (no) 2004-05-05
EP1446123A1 (en) 2004-08-18
RU2004112422A (ru) 2005-04-10
CN1604780A (zh) 2005-04-06
AR036891A1 (es) 2004-10-13
WO2003032995A8 (en) 2004-06-03
IL161380A0 (en) 2004-09-27
US20060229321A1 (en) 2006-10-12
WO2003032995A1 (en) 2003-04-24
SE0103509D0 (sv) 2001-10-19

Similar Documents

Publication Publication Date Title
ES2545205T3 (es) Combinación de azelastina y ciclesonida
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
PT840601E (pt) Thip para o tratamento de desordens do sono
BRPI0111116B8 (pt) imitadores de trombopoietina
DK0695189T3 (da) Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer
CY2012009I2 (el) Αναστολεις της κυκλοπροπυλ-συντηκωμενης διπεπτυλοπεπτιδασης 4, βασισμενοι σε πυρρολιδινη, και μεθοδοι για την παρασκευη των και την χρηση των
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
GB0002336D0 (en) Medicaments
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
CO5580773A2 (es) Rosuvastatina en estados pre dementes
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ATE234359T1 (de) Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
TR200103561T2 (tr) Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları
RS50681B (sr) Kombinacija taksana i ciklin-zavisne kinaze
CO5590922A2 (es) Uso de istradefilina (kw-6002) para el tratamiento de trastornos de la conducta

Legal Events

Date Code Title Description
FA Application withdrawn